3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
4
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Breast Neoplasms
24
Carcinoma, Non-Small-Cell Lung
20
Neoplasms
19
Colorectal Neoplasms
19
Recurrence
17
Pancreatic Neoplasms
17
Multiple Myeloma
15
Advanced Solid Tumors
13
Prostatic Neoplasms
12
Advanced Solid Tumor
12
Stomach Neoplasms
10
Ovarian Neoplasms
10
Leukemia, Myeloid, Acute
10
Carcinoma, Hepatocellular
10
Triple Negative Breast Neoplasms
8
Neoplasm Metastasis
7
Melanoma
7
Squamous Cell Carcinoma of Head and Neck
6
Small Cell Lung Carcinoma
6
Lymphoma, Large B-Cell, Diffuse
6
Head and Neck Neoplasms
6
Glioblastoma
6
Urinary Bladder Neoplasms
5
Solid Tumors
5
Solid Tumor
5
Lymphoma, B-Cell
5
Lung Neoplasms
5
Liver Neoplasms
5
Glioma
5
Endometrial Neoplasms
5
Interventions
Quality of Life
1
Electrocardiography
1
Clinical Laboratory Techniques
1
Bone Marrow Examination
1
Azacitidine
1
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Not yet recruiting
×
Bone Marrow Diseases
×
Clear all
NCT07387354
2026-03-16
MDS
Thomas Jefferson University
Phase 1/2
Not yet recruiting
25 enrolled